Erythromycin A Enol Ether
|
|
|
- CAS-Nr.
- 33396-29-1
- Englisch Name:
- Erythromycin A Enol Ether
- Synonyma:
- EM 523;Isoniazid Impurity 16;Erythromycin impurity B;Erythromycin Impurity 5;Erythromycin impurity 05;Erythromycin A Enol Ether;Erythromycin A Enol EtherI;JFVYXJKGJMUGRG-POECJHBWSA-N;Erythromycin Estolate Impurity E;Erythromycin A enol ether, EvoPure
- CBNumber:
- CB21176304
- Summenformel:
- C37H65NO12
- Molgewicht:
- 715.91
- MOL-Datei:
- 33396-29-1.mol
|
Erythromycin A Enol Ether Eigenschaften
- Schmelzpunkt:
- 133-1350C
- Siedepunkt:
- 791.6±60.0 °C(Predicted)
- Dichte
- 1.20±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- Löslichkeit
- Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 13.45±0.70(Predicted)
- Farbe
- White to Pale Yellow
- CAS Datenbank
- 33396-29-1
Sicherheit
Erythromycin A Enol Ether Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
Verwenden
Erythromycin A enol ether is a degradation product of erythromycin formed under acidic conditions by C6–OH internal attack on the C9 ketone to produce a cyclic enol ether. The rearrangement results in a loss of antibiotic activity. This single reaction was the prime driver for the development of second and third generation erythromycins. Erythromycin A enol ether is an important standard for stability studies.
Erythromycin A Enol Ether Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Erythromycin A Enol Ether Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 86)Lieferanten
- 11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-5-ethyl-3,4-dihydroxy-9-(5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy)-2,4,8,10,12,14-hexamethyl-6,15-dioxa-bicyclo[10.2.1]pentadec-1(14)-en-7-one
- (6R)-6-Deoxy-9-deoxo-6,9-epoxy-8,9-didehydroerythromycin
- 6,9-Epoxy-8,9-didehydro-9-deoxo-6-deoxyerythromycin
- 6-Deoxy-9-deoxo-8,9-didehydro-6,9-epoxyerythromycin
- 6β,9-Epoxy-8,9-didehydro-9-deoxo-6-deoxyerythromycin
- 9-Deoxo-6-deoxy-6,9-epoxy-8,9-didehydroerythromycin
- Erythromycin A Enol Ether
- EM 523
- Erythromycin impurity B
- JFVYXJKGJMUGRG-POECJHBWSA-N
- Erythromycin Impurity 5
- Erythromycin EP Impurity E/Erythromycin A Enol Ether/(2R,3R,4S,5R,8R,9S,10S,11R,12R)-9-[(2,6-dideoxy-3-
C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-
5-ethyl-3,4-dihydroxy-2,4,8,10,12,14-hexamethyl-
11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylohexopyr
- Erythromycin Impurity 5(Erythromycin EP Impurity E)
- Erythromycin Impurit E:(erythromycin A enol ether)
- Erythromycin EP Impurity E (Erythromycin A Enol Ether)
- Erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy-
- Isoniazid Impurity 16
- Erythromycin A Enol EtherI
- Erythromycin Lactobionate EP Impurity E
- Inhibitor,inhibit,Acidic,Erythromycin A enol ether,degradation
- Erythromycin Estolate EP Impurity E
- Erythromycin Ethylsuccinate EP Impurity E
- Erythromycin Estolate Impurity E
- Erythromycin Stearate EP Impurity E
- Erythromycin impurity 05
- Erythromycin A enol ether, EvoPure
- (2R,3R,4S,5R,8R,9S,10S,11R,12R)-9-[(2,6-dideoxy-3-C-methyl- 3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-5-ethyl-3,4-dihydroxy- 2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)- β-D-xylohexopyranosyl]oxy]-6,15-dioxabicyclo[10.2.1]pentadec- 1(14)-en-7-one
- 33396-29-1
- C37H65NO12
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Pharmaceuticals
- Chromatography
- Drugs&Metabolites
- Forensic and Veterinary Standards
- Neat CompoundsAnalytical Standards
- Pharmacology Standards
- Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
- Various Metabolites and Impurities
